Multiple Endocrine Neoplasia Type 4.
Brock P, Kirschner L.
2023 Sep 21. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.
Multiple Endocrine Neoplasia Type 4.
de Herder WW, Hofland J.
2022 Feb 28. In: Feingold KR, Adler RA, Ahmed SF, Anawalt B, Blackman MR, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hamilton E, Hofland J, Jan de Beur S, Kalra S, Kaltsas G, Kapoor N, Kim M, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–.
Multiple endocrine neoplasia type 4 (MEN4): a thorough update on the latest and least known men syndrome.
Ruggeri RM, Benevento E, De Cicco F, Grossrubatscher EM, Hasballa I, Tarsitano MG, Centello R, Isidori AM, Colao A, Pellegata NS, Faggiano A.
Endocrine. 2023 Dec;82(3):480-490. doi: 10.1007/s12020-023-03497-2. Epub 2023 Aug 26.
Multiple endocrine neoplasia type 4 & primary hyperparathyroidism: What the surgeon needs to know.
Watanabe A, Wiseman SM.
Am J Surg. 2022 Sep;224(3):1017-1018. doi: 10.1016/j.amjsurg.2022.04.025. Epub 2022 Apr 25.
Multiple endocrine neoplasia type 4.
Lee M, Pellegata NS.
Front Horm Res. 2013;41:63-78. doi: 10.1159/000345670. Epub 2013 Mar 19.
Multiple endocrine neoplasia type 4: a new member of the MEN family.
Singeisen H, Renzulli MM, Pavlicek V, Probst P, Hauswirth F, Muller MK, Adamczyk M, Weber A, Kaderli RM, Renzulli P.
Endocr Connect. 2023 Jan 24;12(2):e220411. doi: 10.1530/EC-22-0411. Print 2023 Feb 1.
Clinical Features of Multiple Endocrine Neoplasia Type 4: Novel Pathogenic Variant and Review of Published Cases.
Frederiksen A, Rossing M, Hermann P, Ejersted C, Thakker RV, Frost M.
J Clin Endocrinol Metab. 2019 Sep 1;104(9):3637-3646. doi: 10.1210/jc.2019-00082.
Case Report: New CDKN1B Mutation in Multiple Endocrine Neoplasia Type 4 and Brief Literature Review on Clinical Management.
Lavezzi E, Brunetti A, Smiroldo V, Nappo G, Pedicini V, Vitali E, Trivellin G, Mazziotti G, Lania A.
Front Endocrinol (Lausanne). 2022 Mar 9;13:773143. doi: 10.3389/fendo.2022.773143. eCollection 2022.
Clinical Factors Predicting Multiple Endocrine Neoplasia Type 1 and Type 4 in Patients with Neuroendocrine Tumors.
Faggiano A, Fazzalari B, Mikovic N, Russo F, Zamponi V, Mazzilli R, Guarnieri V, Piane M, Visco V, Petrucci S.
Genes (Basel). 2023 Sep 10;14(9):1782. doi: 10.3390/genes14091782.
Multiple Endocrine Neoplasia Type 4: Novel CDNK1B variant and immune anomalies.
Chevalier B, Odou MF, Demonchy J, Cardot-Bauters C, Vantyghem MC.
Ann Endocrinol (Paris). 2020 Jun;81(2-3):124-125. doi: 10.1016/j.ando.2020.04.002. Epub 2020 Apr 10.
